OC
CLOV icon

Oppenheimer & Co’s Clover Health Investments CLOV Stock Holding History

Oppenheimer & Co’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-20,731
Closed -$74K – 1432
2022
Q1 		$74K Buy
+20,731
New +$60.1K ﹤0.01% 1422
2021
Q1 		– Sell
-12,760
Closed -$214K – 1447
2020
Q4 		$214K Buy
+12,760
New +$142K ﹤0.01% 1221

Other funds holding CLOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Oppenheimer & Co's CLOV Position: Q2 2022 in Review

Oppenheimer & Co sold out of Clover Health Investments (CLOV) in Q2 2022, closing a stake of 20,731 shares — an estimated $74K sold.

Oppenheimer & Co first reported a position in CLOV in Q4 2020 and held it in 2 quarters. The position peaked at $214K in Q4 2020. 176 funds tracked by Wall St. Rank hold CLOV as of Q2 2022.

  • Oppenheimer & Co reported no remaining Clover Health Investments position as of Q2 2022 after selling out during the quarter.
  • Oppenheimer & Co sold 20,731 Clover Health Investments shares in Q2 2022, an estimated $74K.
  • Oppenheimer & Co first reported a position in Clover Health Investments in Q4 2020 and held it in 2 quarters.
  • Oppenheimer & Co's Clover Health Investments position peaked at $214K in Q4 2020.
  • 176 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2022.

Based on Oppenheimer & Co's 13F filing for Q2 2022, filed 8 Aug 2022.